Denominator bias in MENA MASLD epidemiology: A call for decision-grade surveillance

dc.contributor.authorEl-Kassas, Mohamed
dc.contributor.authorAlNaamani, Khalid M.
dc.contributor.authorSanai, Faisal M.
dc.contributor.authorYılmaz, Yusuf Nadir
dc.contributor.authorLabidi, Asma
dc.contributor.authorMohammed, Mohammed O.
dc.contributor.authorAlswat, Khalid A.
dc.date.accessioned2026-08-04T06:52:29Z
dc.date.issued2026
dc.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractMetabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent in the Middle East and North Africa (MENA) region, yet published estimates of prevalence and outcomes remain uncertain because the underlying denominators are inconsistently defined. This perspective argues that MENA MASLD epidemiology is systematically biased by three interacting mechanisms: distorted sampling frames, referral pathway selection, and structural undercapture of rural and displaced populations. Much of the current evidence is derived from convenience cohorts concentrated in urban, tertiary care settings where diagnostic availability and follow-up are greater than in the general population, leading to directional rather than random error. In parallel, risk stratification pathways that rely on two-step testing can funnel case detection toward specialty rich settings, overrepresenting advanced disease while missing earlier stages managed outside hepatology services. MASLD nomenclature change and incomplete alignment of coding and clinical documentation may further introduce artefactual inflection points that complicate trend interpretation. We highlight how underdiagnosis and under-recording in primary care propagate bias across downstream estimates and how validation of administrative algorithms and text-based ascertainment can quantify hidden disease reservoirs within routine data systems. Building on regional priority settings, we propose denominator-focused actions: probability-based sampling embedded in noncommunicable disease surveys; purposeful inclusion of rural and displaced groups; linkable data across primary care, laboratories, hospitals, and mortality registries; and harmonized coding and terminology. By decision-grade denominators, we refer to population denominators that are sufficiently representative, transparent, and linkable to support national surveillance, resource allocation, and trial-readiness decisions.
dc.identifier.citationEl-Kassas, M., AlNaamani, K. M., Sanai, F. M., Yilmaz, Y., Labidi, A., Mohammed, M. O., El-Shabrawi, M. H. F., Almattooq, M., Debzi, N., Tumi, A., Ksiaa, M., Yaghi, C., Elbadry, M., Afredj, N., Desoky, M. S., Matar, K., Waked, I., Esmat, G., Elzouki, A.-N., & Alswat, K. A. (2026). Denominator bias in MENA MASLD epidemiology: A call for decision-grade surveillance. Saudi Journal of Gastroenterology. https://doi.org/10.4103/sjg.sjg_87_26
dc.identifier.doi10.4103/sjg.sjg_87_26
dc.identifier.issn1319-3767
dc.identifier.urihttps://doi.org/10.4103/sjg.sjg_87_26
dc.identifier.urihttps://hdl.handle.net/11436/13335
dc.identifier.wosWOS:001782898900001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.institutionauthorYılmaz, Yusuf Nadir
dc.language.isoen
dc.publisherWolters Kluwer Medknow
dc.relation.ispartofSaudi Journal of Gastroenterology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBurden
dc.subjectdenominator bias
dc.subjectepidemiology
dc.subjectMENA region
dc.subjectmetabolic dysfunction‑associated steatotic liver disease (MASLD)
dc.subjectprevalence
dc.titleDenominator bias in MENA MASLD epidemiology: A call for decision-grade surveillance
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
kassas-2026.pdf
Boyut:
1.09 MB
Biçim:
Adobe Portable Document Format

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: